Cyclosporine, Low-Density Lipoprotein, and Cholesterol
- 1 October 1988
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 63 (10) , 1012-1021
- https://doi.org/10.1016/s0025-6196(12)64916-7
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Cyclosporine-Associated Central Nervous System ToxicityNew England Journal of Medicine, 1988
- Central Nervous System Toxicity after Liver TransplantationNew England Journal of Medicine, 1987
- Cyclosporin A inhibits PGE2 release from vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1987
- Increased Concentrations of Cholestanol and Apolipoprotein B in the Cerebrospinal Fluid of Patients with Cerebrotendinous XanthomatosisNew England Journal of Medicine, 1987
- Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Long-Term Treatment of Cerebrotendinous Xanthomatosis with Chenodeoxycholic AcidNew England Journal of Medicine, 1984
- Defective Lipoprotein Receptors and AtherosclerosisNew England Journal of Medicine, 1983
- Liver Transplantation with Use of Cyclosporin a and PrednisoneNew England Journal of Medicine, 1981
- Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimerasDevelopmental Biology, 1981
- Antischistosomal effects of cyclosporin AInflammation Research, 1981